---
title: Congenica Expands in North America with Strategic Appointment
description: Congenica Expands in North America with Strategic Appointment
image: https://blog.congenica.com/hubfs/International-expansion_2-1.jpg
---

- [Our Customers and Partners](http://www.congenica.com/our-customers)
- [Our Product Portfolio](http://www.congenica.com/congenica-products) 
    - **Inherited Diseases** 
          - [Rare Disease](http://www.congenica.com/congenica-rare-disease)
          - [Inherited Cancer](http://www.congenica.com/congenica-inherited-cancer)
          - [Prenatal Health](http://www.congenica.com/congenica-prenatal)
          - [Carrier Screening](http://www.congenica.com/congenica-carrier-screening)
          - [Neurodevelopmental Disorders](http://www.congenica.com/congenica-neuro)
    - **Somatic Oncology** 
          - [Solid Tumours](http://www.congenica.com/congenica-oncology)
    - **Pathogen** 
          - [Pathogen Surveillance](http://www.congenica.com/congenica-pathogen-surveillance)
- [Our Services](http://www.congenica.com/congenica-services) 
    - [Clinical Interpretation Services](http://www.congenica.com/congenica-clinical-interpretation-services)
    - [Professional Services](http://www.congenica.com/professional-services)
    - [Customer Support](http://www.congenica.com/customer-support)
    - [Pharma Services](http://www.congenica.com/pharma-services)
- Resources 
    - [Publications](http://www.congenica.com/publications)
    - [Supporting materials](http://www.congenica.com/resources)
    - [News](https://blog.congenica.com/)
    - [Events and webinars](http://www.congenica.com/events-webinars)
- [About us](http://www.congenica.com) 
    - [Leadership Team](http://www.congenica.com/leadership)
    - [Quality](http://www.congenica.com/quality)
    - [Investors](http://www.congenica.com/investors)
    - [People and Vacancies](http://www.congenica.com/people)
- [Contact us](http://www.congenica.com/contact)

Login

##### Please select your location and reference genome:

[America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/)

[Overview](https://blog.congenica.com) [Congenica Expands in North America with Strategic Appointment](https://blog.congenica.com/2017/01/17/congenica-expands-north-america-strategic-appointment)

![Congenica Expands in North America with Strategic Appointment](https://blog.congenica.com/hubfs/International-expansion_2-1.jpg)

 News

# Congenica Expands in North America with Strategic Appointment

 1/17/2017     |    0 min read

  
***Genomics Analysis Leader Appoints Dr Shikha O’Brien as Chief Business Officer***

*16th January 2017, Cambridge UK*

Congenica, a world leading developer of genome analysis and interpretation technologies, expands its operations in the US with the announcement that it has recruited Dr Shikha O’Brien as its Chief Business Officer. Dr O’Brien will be based out of San Diego, California, where she will oversee the Global Sales and Marketing operations. Established in 2014, Congenica has grown rapidly as progressive genetic medicine centres adopt its web-based rare disease diagnostic platform, Sapientia™, for clinical use. Dr O’Brien, an accomplished executive in the Life Sciences and Healthcare informatics field is joining the genomics company as it seeks to drive global growth and establish strategic partnerships.

Dr Tom Weaver, Congenica CEO, has welcomed the appointment of Dr O’Brien. He said: “We are delighted to have Shikha O’Brien join our Executive Team as we grow our global client base. Shikha has significant experience with big data analytics and genomic-based clinical and research applications with a strong record of growing companies in our segment. We see her experience in digital healthcare and working with the pharma industry as a core element in our strategy of global expansion, with the current focus on the US market and China.”

Dr O’Brien said: “Congenica is a rapidly expanding company with proven technology that is driving the genomics revolution in precision medicine. In clinical applications, Sapientia’s genome analysis and interpretation platform is already delivering the highest diagnostic yield in accurate and rapid identification of rare and inherited diseases. Working closely with Congenica’s world renowned scientific leadership team, we will be building upon these advances to mainstream the Sapientia technology”

Her previous roles included establishing start-ups and bringing innovative solutions in the Life Sciences and Healthcare informatics. Her particular focus is in value-based leadership and in becoming the voice of the customers which has resulted in long term commercial success for many companies. Dr O’Brien will be based out of San Diego, California, where she will oversee the Global Sales and Marketing function and manage Congenica’s operations in the US. San Diego will be Congenica’s first office outside of the UK with plans to establish another one on the east coast.

Congenica will be presenting at the upcoming Precision Medicine World Conference Silicon Valley on Jan 23rd2017 “Rare Disease Diagnosis – Shortening Odysseys, Improving Outcomes”.

---

<http://www.facebook.com/share.php?u=https://blog.congenica.com/2017/01/17/congenica-expands-north-america-strategic-appointment&utm_medium=social&utm_source=facebook> <http://www.linkedin.com/shareArticle?mini=true&url=https://blog.congenica.com/2017/01/17/congenica-expands-north-america-strategic-appointment&utm_medium=social&utm_source=linkedin> <https://twitter.com/intent/tweet?original_referer=https://blog.congenica.com/2017/01/17/congenica-expands-north-america-strategic-appointment&utm_medium=social&utm_source=twitter&url=https://blog.congenica.com/2017/01/17/congenica-expands-north-america-strategic-appointment&utm_medium=social&utm_source=twitter&source=tweetbutton&text=>

### Related articles

![SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine](https://blog.congenica.com/hs-fs/hubfs/New%20logos/Congenica%20%26%20SeqOne%20Logo%20Without%20Tagline%20RGB.png?width=320&height=192&name=Congenica%20%26%20SeqOne%20Logo%20Without%20Tagline%20RGB.png)

 9/2/2025

#### [SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine](https://blog.congenica.com/seqone-acquires-congenica-to-create-a-global-leader-in-ai-powered-genomic-medicine)

Strategic acquisition of UK genomics leader Congenica reinforces SeqOne market position and footprint - servicing over 160 labs in 30+ countries

![Congenica showcased in Genomics Spotlight 2024 Report](https://blog.congenica.com/hs-fs/hubfs/male%20doc%20with%20child%20and%20mum%20light%20small%20.jpg?width=320&height=192&name=male%20doc%20with%20child%20and%20mum%20light%20small%20.jpg)

 11/6/2024

#### [Congenica showcased in Genomics Spotlight 2024 Report](https://blog.congenica.com/congenica-showcased-in-recently-launched-genomics-spotlight-2024-report)

We are thrilled to announce that Congenica is one of the companies showcased in the recently launched Genomics Spotlight 2024 report produced by the UK Department for Business and Trade (DBT).

![Congenica Named Best Genomic Data Analysis Software Company 2024 by GHP](https://blog.congenica.com/hs-fs/hubfs/Onco%20.png?width=320&height=192&name=Onco%20.png)

 6/19/2024

#### [Congenica Named Best Genomic Data Analysis Software Company 2024 by GHP](https://blog.congenica.com/congenica-named-best-genomic-data-analysis-software-company-2024-by-ghp)

We are thrilled to announce that Congenica has been awarded the title of "Best Genomic Data Analysis Software Company 2024" by Global Health & Pharma Magazine. 

##### Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.

- [Privacy Policy](http://www.congenica.com/privacy-policy)
- [Cookie Policy](http://www.congenica.com/cookie-policy)

<https://twitter.com/congenica> <https://en-gb.facebook.com/congenica/> <https://www.linkedin.com/company/congenica/> 

Log in to Congenica

##### Please select your location and reference genome:

[America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/)

![CE](https://blog.congenica.com/hs-fs/hubfs/CE.png?width=80&height=80&name=CE.png) ![ISO-27001](https://blog.congenica.com/hs-fs/hubfs/ISO-27001.jpg?width=80&height=80&name=ISO-27001.jpg) ![TR-Testmark_9000030872_EN_2024_CMYK](https://blog.congenica.com/hs-fs/hubfs/2023%20website%20images/TR-Testmark_9000030872_EN_2024_CMYK.png?width=80&height=80&name=TR-Testmark_9000030872_EN_2024_CMYK.png) ![HIPAA Compliant](https://blog.congenica.com/hs-fs/hubfs/HIPAA%20Compliant.png?width=80&height=80&name=HIPAA%20Compliant.png)

Copyright © 2026 Congenica Ltd. Company number: 8273616 Registered in England and Wales.